Tag: ads

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross proceeds to Legend Biotech from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Legend Biotech, are expected to be approximately $226 million, excluding any proceeds from the exercise of the underwriters’ option to purchase additional ADSs. The offering is expected to close on June 23, 2026, subject to customary closing conditions.

Integration with Viasat Ads unlocks premium in-flight advertising inventory through automated, data-driven buying

Introduces Industry-First Loyalty Program for All Customers with Cash Back in Verizon Dollars, Daily Surprises, and the End of Device Upgrade and Activation Fees

Uklon Store, Uklon’s first move into everyday commerce, opens with flower deliveries in Kyiv. Customers can buy a bouquet in a few taps and have it delivered the same day by Uklon drivers.

Uklon Store marks the company’s entry into e-commerce, introducing a scalable, asset-light and margin-accretive revenue stream that supports diversification, improves monetization of the existing user base, and underpins long-term growth and shareholder value.

GUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading advanced air mobility (“AAM”) technology platform company, today announced its unaudited financial results for the first quarter ended March 31, 2026.

Châtillon, France, le 8 juin (22 :30 CET) 2026